Compare stocks

Up to 2 stocks side by side – every figure with value, threshold and date. No overall score, no ordering by result.

2 stocks selected – remove one to add another. Up to 4 stocks with Premium. Premium

Comparison: DGX, VRTX
Figure DGX × Quest Diagnostics Health Care VRTX × Vertex Pharmaceuticals Health Care
Quality checksfrom the annual figures, without price-based criteria
Quality not available 6 of 8 criteria with data met
Growth not available 7 of 7 criteria with data met
Dividend not available 0 of 1 criteria with data met · 6 without data
Financial strength not available 5 of 5 criteria with data met · 1 without data
Key figuresValue, distance to the fixed threshold, sector median alongside
Net marginThreshold: above 10% not available 32.9% Distance +22.9 ppSector median 12.9% (63 stocks)
Operating marginThreshold: above 15% not available 34.8% Distance +19.8 ppSector median 17.0% (54 stocks)
Gross marginThreshold: above 40% not available 86.2% Distance +46.2 ppSector median 61.8% (49 stocks)
Return on equityThreshold: above 15% not available 21.2% Distance +6.2 ppSector median 12.8% (54 stocks)
Free cash flow marginThreshold: above 10% not available 26.6% Distance +16.6 ppSector median 14.5% (61 stocks)
Profitable yearsThreshold: 5 of 5 not available 4 of 5
Years with positive free cash flowThreshold: 3 of 3 not available 2 of 3
Revenue growth 5 yearsThreshold: above 5% per year not available +14.1% per year Distance +9.1 ppSector median +7.8% per year (60 stocks)
EPS growth 5 yearsThreshold: above 5% per year not available +8.3% per year Distance +3.3 ppSector median +8.3% per year (47 stocks)
EquityThreshold: above 0 not available 18.7B USD
Equity ratioThreshold: above 30% not available 72.8% Distance +42.8 ppSector median 44.2% (63 stocks)
Debt / equityThreshold: at most 1.0 not available 0.00 Distance −1.00Sector median 0.66 (50 stocks)
Piotroski F-ScoreThreshold: at least 7 not available 6 of 8 1 criterion without data
DepthEarnings quality, consistency, valuation in words, trailing 12 months and sector rank
Cash flow ÷ profit Earnings quality, covered from 1.0 not available 0.92x cash inflow slightly below earningsas of fiscal year 2025
Loss years Consistency, last up to 10 fiscal years not available 2 of 10 as of fiscal year 2025
Years with lower revenue Consistency, last up to 10 fiscal years not available 0 of 10 as of fiscal year 2025
Years without a dividend cut Dividend per share, split-adjusted not available not available
P/E against its own 5-year median Valuation against its own history above its own median distance in percent with a free account above its own median distance in percent with a free account
Net margin 12 months trailing 12 months per SEC 9.5% 12 months to Sep 30, 2026 30.7% 12 months to Sep 30, 2026
Quarterly revenue vs. a year earlier latest quarter +10.0% grown for 11 quarters in a row +11.8% grown for at least 16 quarters in a row
Quarterly earnings vs. a year earlier latest quarter +27.3% −39.6%
Sector rank net margin 0 to 100, 100 = strongest value 40 98
Sector rank return on equity 0 to 100, 100 = strongest value 53 73
Sector rank revenue growth (5 yrs) 0 to 100, 100 = strongest value 13 84
ChartPosition in words – distances only when signed in
position relative to the 200-day line more than 10% above As of Nov 19, 2026 above As of Nov 20, 2026
Dividend and fiscal year
Dividend paidin the last 5 fiscal years not available no dividend
Latest annual figures no usable financial figures Fiscal year to Dec 31, 2025

How is this made? · Figures from the annual reports (SEC) · As of Nov 22, 2026 · not investment advice

↑ ↓ select · Enter open · Esc close